Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX1GNA
|
||||
| Drug Name |
(S)-2-((S)-1-(4-(1H-pyrazol-4-yl)phenyl)-2,2,2-trifluoroethylamino)-N-((S)-1-cyano-2-phenylethyl)-4-fluoro-4-methylpentanamide
|
||||
| Synonyms |
CHEMBL1289764
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H27F4N5O
|
||||
| Canonical SMILES |
CC(C)(F)C[C@H](N[C@@H](c1ccc(cc1)c2cn[nH]c2)C(F)(F)F)C(=O)N[C@@H](Cc3ccccc3)C#N
|
||||
| InChI |
InChI=1S/C26H27F4N5O/c1-25(2,27)13-22(24(36)34-21(14-31)12-17-6-4-3-5-7-17)35-23(26(28,29)30)19-10-8-18(9-11-19)20-15-32-33-16-20/h3-11,15-16,21-23,35H,12-13H2,1-2H3,(H,32,33)(H,34,36)/t21-,22-,23-/m0/s1
|
||||
| InChIKey |
CGAOFGCVDRGRSC-VABKMULXSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.